Drug profile · INN
piflufolastat f-18
PYLARIFY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
piflufolastat f-18 (PYLARIFY) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN piflufolastat f-18
Brand PYLARIFY
Route INTRAVENOUS
Formulation SOLUTION
Frequently asked questions
What is piflufolastat f-18?
piflufolastat f-18 (PYLARIFY) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for piflufolastat f-18?
PYLARIFY is a marketed brand name for piflufolastat f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of piflufolastat f-18?
piflufolastat f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.